Serum Institute of India Pvt. Ltd.

Plus: Maxion raises series A to develop mAbs against ion channels, GPCRs and updates from Arrowhead, Moderna, Galera, Codagenix, Nanite

Bleeding continued in biopharma in second quarter, with median market caps down in all tiers

Advisory committee says another non-mRNA vaccine is needed, expresses desire to encourage more COVID-19 vaccine development

SII to manufacture and commercialize GreenLight’s planned shingles vaccine; deal could include two other RNA products

Rostec and other Russian companies hit by sanctions have links to U.S. biotechs, VC

Plus Novavax gains India EUA, Spero, Leo and more

Covovax is the ninth COVID-19 vaccine to be listed by WHO

Plus: First authorization for Novavax, delay for Spikevax and more

Cue the IPO, plus DMD data, Jasper SPAC, GeNeuro-Northwestern, Everest-AbCellera CinRx newco and more

Biocon partners with Serum Institute, plus Santé’s $260M fund, IASO Bio’s $108M series C, Everest in $12M renal deal and more